About
Jon Rees is a UK biotech executive and life-sciences ecosystem operator best known as CEO of MitoRx Therapeutics, a preclinical mitochondrial therapeutics company. Earlier, he spent a decade as CEO of OBN/BioTrinity, where he helped grow one of the UK's key emerging-biotech networks and investment conferences. He has also worked as a consultant in rare diseases and as a trustee of PKD UK.
Areas of interest
biotechdrug developmentrare diseasesmetabolic diseasemyopathiesneurodegenerationmitochondrial therapeuticslife sciences investing ecosystementrepreneurship